Physician profile
Henry M Lo
NPI 1679644553
$2,114.99
in general payments reported to CMS, 2019-2025
8 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $12.70 · 2021: $93.61 · 2022: $81.33 · 2023: $559 · 2024: $754 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $618.30 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Boston Scientific Corporation | $441.16 | 2021-2025 | Avvigo Guidance System, Rotapro |
| Medtronic, INC. | $341.92 | 2024-2025 | Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $223.36 | 2022-2024 | Diamondback Coronary, Xience Skypoint, Pressurewire |
| Shockwave Medical, INC | $216.64 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $121.25 | 2019 | |
| Terumo Medical Corporation | $80.83 | 2023 | Azur Cx Detachable, Angio-Seal, Glidewire |
| Cardiva Medical, INC. | $71.53 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.